Psilocybin therapy for females with anorexia nervosa: a phase 1, open-label feasibility study.

"data availability the datasets generated and/or analyzed during the current study are available in the dryad data repository and available upon reasonable request. data availability the datasets generated and/or analyzed during the current study are available in the dryad"

"Competing interests S.K.P. is a senior clinical consultant for Compass Pathways, the funder of the study, and receives compensation for this role. Additionally, she is a sub-investigator for an upcoming Compass-sponsored randomized trial evaluating psilocybin for anorexia nervosa and is a lead therapist for this trial and other Compass-sponsored trials. W.H.K. has served as a consultant and advisor for Compass Pathways, the funder of this study, and has received compensation for these roles. W.H.K. has also received financial support for this study and for an upcoming randomized controlled trial evaluating psilocybin for anorexia nervosa, which is sponsored by Compass Pathways. Additionally, he serves as site principal investigator for the upcoming referenced trial. S.S., T.G., K.Y., A.B., J.T. and D.F.M. report no competing interests."

"A special thank you to Compass Pathways and their team for funding this study (W.H.K.) and to Phastar for performing statistical analyses."